Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00868855
First received: March 19, 2009
Last updated: November 18, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)